BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36563827)

  • 1. Hypoglycemic effects of different molecular weight konjac glucomannans via intestinal microbiota and SCFAs mediated mechanism.
    Deng J; Zou X; Liang Y; Zhong J; Zhou K; Zhang J; Zhang M; Wang Z; Sun Y; Li M
    Int J Biol Macromol; 2023 Apr; 234():122941. PubMed ID: 36563827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemic effects and mechanism of different molecular weights of konjac glucomannans in type 2 diabetic rats.
    Deng J; Zhong J; Long J; Zou X; Wang D; Song Y; Zhou K; Liang Y; Huang R; Wei X; Li M; Sun Y
    Int J Biol Macromol; 2020 Dec; 165(Pt B):2231-2243. PubMed ID: 33058981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular properties and gut health benefits of enzyme-hydrolyzed konjac glucomannans.
    Yin JY; Ma LY; Xie MY; Nie SP; Wu JY
    Carbohydr Polym; 2020 Jun; 237():116117. PubMed ID: 32241414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fiber konjac glucomannan exerts an antidiabetic effect via inhibiting lipid absorption and regulation of PPAR-γ and gut microbiome.
    Jayachandran M; Christudas S; Zheng X; Xu B
    Food Chem; 2023 Mar; 403():134336. PubMed ID: 36191423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota plays a predominant role in affecting hypolipidemic effect of Deacetylated Konjac Glucomannan (Da-KGM).
    Zou X; Deng J; Wang Z; Zhang M; Sun Y; Li M
    Int J Biol Macromol; 2022 May; 208():858-868. PubMed ID: 35339502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
    Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
    Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced hypoglycemic effects of konjac glucomannan combined with Polygonatum cyrtonema Hua polysaccharide in complete nutritional liquid diet fed type 2 diabetes mice.
    Chang L; Goff HD; Ding C; Liu Q; Zhao S; Tao T; Lu R; Gao Y; Wu H; Guo L
    Int J Biol Macromol; 2024 May; 266(Pt 1):131121. PubMed ID: 38522692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intervention effects of konjac glucomannan with different molecular weights on high-fat and high-fructose diet-fed obese mice based on the regulation of gut microbiota.
    Liu Q; Fang J; Huang W; Liu S; Zhang X; Gong G; Huang L; Lin X; Wang Z
    Food Res Int; 2023 Mar; 165():112498. PubMed ID: 36869507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of konjac glucomannan with different molecular weights on gut microflora with antibiotic perturbance in in vitro fecal fermentation.
    Mao YH; Xu YX; Li YH; Cao J; Song FL; Zhao D; Zhao Y; Wang ZM; Yang Y
    Carbohydr Polym; 2021 Dec; 273():118546. PubMed ID: 34560958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats.
    Yan H; Lu J; Wang Y; Gu W; Yang X; Yu J
    Phytomedicine; 2017 Mar; 26():45-54. PubMed ID: 28257664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral konjac glucomannan for prevention of ionizing radiation-induced injury by regulating gut microbiota and increasing short chain fatty acids.
    Liu D; Zhuang B; Wei M; Yuan T; Li J; Deng P; Du L; Yuan B; Jin Y
    Int J Biol Macromol; 2023 Jun; 240():124402. PubMed ID: 37044326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection.
    Seekatz AM; Theriot CM; Rao K; Chang YM; Freeman AE; Kao JY; Young VB
    Anaerobe; 2018 Oct; 53():64-73. PubMed ID: 29654837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats.
    An Y; Dai H; Duan Y; Cheng L; Shi L; He C; Wang C; Lv Y; Li H; Zhang H; Huang Y; Fu W; Sun W; Zhao B
    Chin Med; 2023 May; 18(1):49. PubMed ID: 37147692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.
    Yi ZY; Chen L; Wang Y; He D; Zhao D; Zhang SH; Yu R; Huang JH
    Acta Diabetol; 2022 Oct; 59(10):1295-1308. PubMed ID: 35857109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin Sensitivity-Enhancing Activity of Phlorizin Is Associated with Lipopolysaccharide Decrease and Gut Microbiota Changes in Obese and Type 2 Diabetes (db/db) Mice.
    Mei X; Zhang X; Wang Z; Gao Z; Liu G; Hu H; Zou L; Li X
    J Agric Food Chem; 2016 Oct; 64(40):7502-7511. PubMed ID: 27635781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of konjac glucomannan on gut microbiome with antibiotic perturbation in mice.
    Mao YH; Xu Y; Song F; Wang ZM; Li YH; Zhao M; He F; Tian Z; Yang Y
    Carbohydr Polym; 2022 Aug; 290():119476. PubMed ID: 35550768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota.
    Zhao L; Lou H; Peng Y; Chen S; Fan L; Li X
    Diabetes Res Clin Pract; 2020 Nov; 169():108418. PubMed ID: 32891692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Dietary Fiber Supplementation on Fatty Acid Metabolism and Intestinal Microbiota Diversity in C57BL/6J Mice Fed with a High-Fat Diet.
    Zhai X; Lin D; Zhao Y; Li W; Yang X
    J Agric Food Chem; 2018 Dec; 66(48):12706-12718. PubMed ID: 30411889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of cellulose and soluble fibers (pectin, konjac glucomannan, inulin) on fecal water toxicity toward Caco-2 cells, fecal bacteria enzymes, bile acid, and short-chain fatty acids.
    Chen HL; Lin YM; Wang YC
    J Agric Food Chem; 2010 Sep; 58(18):10277-81. PubMed ID: 20799709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota transplantation and replenishment of short-chain fatty acids protect against chronic cerebral hypoperfusion-induced colonic dysfunction by regulating gut microbiota, differentiation of Th17 cells, and mitochondrial energy metabolism.
    Su SH; Wu YF; Lin Q; Zhang L; Wang DP; Hai J
    J Neuroinflammation; 2022 Dec; 19(1):313. PubMed ID: 36567333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.